J Clin Med Res
Journal of Clinical Medicine Research, ISSN 1918-3003 print, 1918-3011 online, Open Access
Article copyright, the authors; Journal compilation copyright, J Clin Med Res and Elmer Press Inc
Journal website http://www.jocmr.org

Original Article

Volume 8, Number 2, February 2016, pages 141-146

Are the Dysnatremias a Permanent Threat to the Critically Ill Patients?

Anibal Basile-Filhoa, Mayra Goncalves Meneguetia, Edson Antonio Nicolinia, Alessandra Fabiane Lagoa, c, Edson Zangiacomi Martinezb, Maria Auxiliadora-Martinsa

aDivision of Intensive Care, Department of Surgery and Anatomy, Ribeirao Preto Medical School, University of Sao Paulo, SP 14049-900 Ribeirao Preto, Brazil
bDepartment of Social Medicine (Statistics), Ribeirao Preto Medical School, University of Sao Paulo, SP 14049-900 Ribeirao Preto, Brazil
cCorresponding Author: Alessandra Fabiane Lago, Division of Intensive Care, Department of Surgery and Anatomy, Ribeirao Preto Medical School, University of Sao Paulo, SP 14049-900 Ribeirao Preto, Brazil

Manuscript accepted for publication December 08, 2015
Short title: Dysnatremias in the ICU
doi: http://dx.doi.org/10.14740/jocmr2425w


Backgroud: The dysnatremias (hyponatremia and hypernatremia) are relatively common findings on admission of intensive care unit (ICU) patients and may represent a major risk. The aim of the study was to assess the ability of serum sodium levels and the Acute Physiology and Chronic Health Evaluation II (APACHE II) to predict mortality of surgical critically ill patients.

Methods: One hundred and ninety-five surgical patients (62% males and 38% females; mean age of 51.8 ± 17.3 years) admitted to the ICU in the postoperative phase were retrospectively studied. The patients were divided into survivors (n = 152) and non-survivors (n = 43). APACHE II, and serum sodium levels at admission, 48 h and discharge were analyzed by generation of receiver operating characteristic (ROC) curves.

Results: The mean APACHE II was 16.3 ± 8.3 (13.6 ± 6.1 for survivors and 25.5 ± 8.5 for non-survivors). The area under the ROC curve for APACHE II was 0.841 (0.782 - 0.889) and 0.721 (0.653 - 0.783), 0.754 (0.653 - 0.783) and 0.720 (0.687 - 0.812) for serum sodium level at admission, 48 h and discharge, respectively.

Conclusion: Even though APACHE II scoring system was the most effective index to predict mortality in the surgical critically ill patients, the serum sodium levels on admission may also be used as an independent predictor of outcome.

Keywords: APACHE; Hyponatremia; Hypernatremia; Mortality; Intensive care


The body sodium imbalance may be associated with increased mortality of critically ill patients. Evidence suggests that changes in the serum sodium level on admission to the intensive care unit (ICU) may lead to a poor outcome [1, 2]. Indeed, the dysnatremias (hyponatremia and hypernatremia) are relatively common findings on admission of these patients to the ICU [3, 4], and can affect various physiological organ systems [4-7].

The hypernatremia is an electrolyte disorder and when present can also represent an independent risk factor for mortality. The elevation of serum sodium levels due to, generally, lack of free water, leads to an increase in serum osmolarity, which can alter the distribution of water between intra- and extracellular compartments, and cause intracellular dehydration. These changes can result in adverse effects and contribute to increasing morbidity and mortality [1-6, 8-12]. The hypernatremia acquired during the ICU stay can also act as an independent risk factor for mortality in patients in critical condition [4].

The aim of this study was to assess the ability of serum sodium levels and the Acute Physiology and Chronic Health Evaluation II (APACHE II) to predict mortality of surgical critically ill patients.


This study was conducted in a nine-bed adult ICU of Clinics Hospital of Ribeirao Preto Medical School of the University of Sao Paulo (FMRP-USP). This tertiary ICU admits case-mix patients, such as clinical cases in critical condition, transplants and surgical patients in early postoperative phase. The research protocol was approved by the Research Ethics Committee of Hospital das Clinicas da Faculdade de Medicina de Ribeirao Preto (Protocol 7076/2010). Surgical adult patients admitted to the ICU between 2013 and 2014 were analyzed. Data relative to diagnosis upon ICU admission, comorbidities, APACHE II and death risk scores were recorded. Demographic data of groups of patients designated survivors and non-survivors are also reported. Data for calculation of the APACHE II [13] death risk score were collected during the first 24 h after patient admission. Thus, the values of serum sodium measured within 24 h after ICU admission, 48 h after admission and at discharge were collected. Normal serum sodium was defined a serum sodium level between 136 and 144 mmol/L [1, 12, 14, 15].

Statistical analysis

Comparison of the demographic and clinical data of the patients (survivors versus non-survivors) was accomplished using a Student’s t-test for mean value. Variables of demographic and clinical data of the patients (survivors and non-survivors) were expressed as mean ± standard deviation. The capability of each index (APACHE II, sodium admission, sodium 48 h and sodium discharge) to predict mortality of surgical patients was described by receiver operating characteristic (ROC) curves. The area under the ROC curve (AUC) was used as a measure of overall index accuracy, and its significance was tested using the Wilcoxon test. Comparison of the AUC from the different indexes was done using the non-parametric test proposed by DeLong et al [16]. The significance level was set at P < 0.05. Statistical analyses were performed using the MedCalc software version 12.


This retrospective study included 195 patients (62% males and 38% females; mean age of 51.8 ± 17.3 years) admitted to the ICU in the postoperative phase. The patients were divided into survivors (n = 152) and non-survivors (n = 43). The mean APACHE II was 16.3 ± 8.3 (13.6 ± 6.1 for survivors and 25.5 ± 8.5 for non-survivors, P < 0.05). The death risk (calculated from APACHE II) was 25.3 ± 24.1 (18 ± 17.3 for survivors and 25.5 ± 8.5 for non-suvivors, P < 0.05). Non-oncologic surgery corresponded to 68.7% of admissions to the ICU. The ICU overall mortality was 22%, whereas hospital mortality was 31.7%. When patients were divided into survivors (n = 152) and non-survivors (n = 43), the observed length of stay in the ICU was 3.24 ± 3.8 and 8.2 ± 8.7 days for survivors and non-survivors, respectively (P < 0.05). The use of mechanical ventilation was higher in the non-survivors group when compared with survivors (1.6 ± 3.6 vs. 6.13 ± 6.0 days). Demographic, clinical, and comparison data between survivors and non-survivors are summarized in Table 1.

Table 1.
Click to view
Table 1. General Characteristics of the Surgical Patients Admitted to ICU*

The AUC for APACHE II was 0.841 (95% CI: 0.782 - 0.889; sensitivity: 79.3; specificity: 77.8). For sodium admission, the AUC was 0.721 (95% CI: 0.653 - 0.783; sensitivity: 64.7; specificity: 71.1). The sodium 48 h and sodium discharge showed an AUC of 0.754 (95% CI: 0.687 - 0.812; sensitivity: 68.7; specificity: 77.8) and 0.720 (95% CI: 0.651 - 0.782; sensitivity: 76.7; specificity: 66.7), respectively. The comparisons of ROC curves for these indexes are depicted in Figure 1 and described in Table 2.

Figure 1.
Click for large image
Figure 1. Receiver operating characteristic (ROC) curves of Acute Physiology and Chronic Health Evaluation II (APACHE II), serum sodium level on admission, sodium 48 h after admission and sodium at discharge of patient from ICU.

Table 2.
Click to view
Table 2. Comparison of Areas Under the Curve (AUC) of Receiver Operating Characteristic (ROC) for Different Predictors at ICU

The hyponatremia (Na < 136 mmol/L), normal sodium levels (136 - 144 mmol/L) and hypernatremia (Na > 144 mmol/L) represented 34.9% (64/4, survivors and non-survivors), 43.4% (78/26) and 11.7% (10/13) of patients, respectively (Table 3).

Table 3.
Click to view
Table 3. Distribution of Different Serum Sodium Levels Between Survivors and Non-Survivors Present on Admission of the Surgical Patient to ICU

As demonstrated below in Figure 2, the median values for sodium admission, sodium 48 h and sodium discharge were 137, 138 and 137 mmol/L for survivors and 140, 144 and 145 for non-survivors, respectively.

Figure 2.
Click for large image
Figure 2. Boxplot of serial serum sodium levels (in mmol/L), distributed by groups of patients of survivors (S) and non-survivors (NS) for sodium admission (A), sodium 48 h (B) and sodium discharge (C).

This restrospective study, based on a binary outcome (survivors and non-survivors) modeling, was designed to investigate the ability of sodium serum levels and APACHE II to predict mortality of surgical critically ill patient.

Hyponatremia is usually defined as a value of serum sodium < 130 mmol/L [17]. This electrolyte imbalance is undoubtedly the most common in clinical practice in all medical services. DeVita et al [8] have demonstrated an incidence of hyponatremia in the ICU of about 30%, whereas Bennani et al [18] in a cohort of 2,188 patients found that 300 of them (13.7%) with hyponatremia on admission. However, other studies showed a higher incidence of hyponatremia of 34.3% [19]. These data are comparable to those demonstrated in our study showing a high incidence of hyponatremia on admission to ICU (34.9%). Hyponatremia can occur due to organic dysfunction (liver or heart failure), adrenal insufficiency, diuretic use and inappropriate secretion of the antidiuretic hormone (ADH) [5]. Additionally, hyponatremia is a predictor of increased mortality in several diseases such as congestive heart failure, community-acquired pneumonia, and even in case-mix hospitalized patients [20]. Moreover, nausea, pain, stress, and infusion of volume have a tendency to increase levels of ADH in the preoperative phase and may enhance the incidence of hyponatremia [21]. Darmon et al [2] demonstrated that mild hyponatremias (serum sodium value ≥ 125 and < 130) are independently associated with worse prognosis of patients, adjusted for severity and comorbidities. These authors pointed out the prognostic consequences of borderline dysnatremias. Padhi et al [19] found in their study that patients with hyponatremia had a longer ICU length of stay (P = 0.02), and days of mechanical ventilation (P < 0.05) with consequent increased rate of mortality (P = 0.01), compared to patients with normal serum sodium. Leung et al [22] studied a total of 75,423 patients with preoperative hyponatremia (serum sodium < 135 mEq/L) and compared with 888,840 patients with sodium levels within the normal range (135 - 144 mEq/L). These authors stated that preoperative hyponatremia was associated with a higher risk of 30 days postoperative mortality (5.2% versus 1.3%; odds ratio (OR): 1.44; 95% CI: 1.38 - 1.50).

The hypernatremia is defined to a serum sodium level > 144 mEq/L [15]. Since the serum sodium is determined by the ratio between the amount of sodium in the serum and the amount of water in the plasma, hypernatremia appears from any excess of sodium such as the administration of hypertonic fluids, hypotonic fluid loss (water free) or a combination of both. Several factors can predispose the ICU patient to hypernatremia as lack of free water, the administration of hipertonic solutions, renal water loss, the use of diuretics, fluid losses through gastrointestinal drainage, fever, fistulas and open wounds [23]. Although less frequent than hyponatremia, some studies have shown an incidence of hypernatremia of 2.5% in ICU admissions [24, 25]. In the present study, 12% of patients presented hypernatremia on intensive care admission and the mortality was very high (56.5%, i.e., 13 out of 23 patients). Mortality rates in hypernatremia patients, especially those in ICU, are very high, ranging from 15% to 50%, depending on the severity of this disorder [26, 27]. Lindner et al [4] evaluated 981 critical patients and identified in a multivariate analysis that hypernatremia played a role of an independent risk factor for mortality and relative risk of 2.1 (95% CI: 1.4 - 3.3). Bihari et al [14] while investigating 436,209 patients admitted to ICU found that patients with hypernatremia (serum sodium ≥ 160 mmol/L) had a higher chance of death, with OR of 4.2 and 95% CI of 3.6 - 4.9. However, these authors did not find differences in the chances of death in patients with normal sodium compared with hypernatremia in patients with respiratory diseases. Additionally, Waite et al [28] demonstrated in 207,702 critical patients, an incidence of 4.3% of hypernatremia and its relationship as independent risk to predict mortality with a relative risk of 1.34 and 95% CI of 1.4 - 1.45. The authors have also shown that the risk of death increases for severe hypernatremia. However, the duration of hypernatremia did not influence mortality.

The comparison of serum sodium and APACHE II as a predictor of mortality, the AUC for the APACHE II, sodium admission and sodium 48 h was 0.841, 0.721 and 0.754, respectively. These results demonstrate that APACHE II in this study performed better in the prediction of mortality. Even though APACHE II is one of the most common prognostic index used in the ICU worldwide, this score system employs multiple variables such as 12 routine physiologic measurements, age, comorbidities, elective or postemergency surgery, Glasgow coma scale and diagnostic category weight [13]. Therefore, serum sodium levels migth be used as a single predictor of mortality in surgical patients.

The present cohort of 195 patients was able to detect that persistence of hypernatremia, even borderline (Fig. 2), showed a very high mortality (10/23 patients: 56.5%, Table 3) and therefore can play an independent role in mortality prediction of critically ill patients. However, further studies with a larger cohort should be carried out to detect the impact of dysnatremias on survival rates of surgical criticallly ill patients.


The results of the present investigation demonstrated the prognostic ability of the APACHE II scoring system for prediction of the mortality of surgical critically ill patients upon ICU admission. Additionally, even though APACHE II was the most effective index to predict mortality, and hypernatremia on admission may also be used as an independent risk factor. Furthermore, these data suggest that the goal to increase the chances of survival of patients is to adjust serum sodium levels, especially hypernatremia, that have a relationship with mortality of these patients.


We are thankful to the ICU staff for their technical assistance in data acquisition and to Fundacao de Amparo ao Ensino, Pesquisa e Assistencia (FAEPA) of Clinics Hospital, Ribeirao Preto Medical School, University of Sao Paulo, Brazil for financial support.

Conflict of Interest

The authors declare that there is no conflict of interests regarding the publication of this paper.

  1. Funk GC, Lindner G, Druml W, Metnitz B, Schwarz C, Bauer P, Metnitz PG. Incidence and prognosis of dysnatremias present on ICU admission. Intensive Care Med. 2010;36(2):304-311.
    doi pubmed
  2. Darmon M, Diconne E, Souweine B, Ruckly S, Adrie C, Azoulay E, Clec'h C, et al. Prognostic consequences of borderline dysnatremia: pay attention to minimal serum sodium change. Crit Care. 2013;17(1):R12.
    doi pubmed
  3. Polderman KH, Schreuder WO, Strack van Schijndel RJ, Thijs LG. Hypernatremia in the intensive care unit: an indicator of quality of care? Crit Care Med. 1999;27(6):1105-1108.
    doi pubmed
  4. Lindner G, Funk GC, Schwarz C, Kneidinger N, Kaider A, Schneeweiss B, Kramer L, et al. Hypernatremia in the critically ill is an independent risk factor for mortality. Am J Kidney Dis. 2007;50(6):952-957.
    doi pubmed
  5. Adrogue HJ, Madias NE. Hyponatremia. N Engl J Med. 2000;342(21):1581-1589.
    doi pubmed
  6. Adrogue HJ, Madias NE. Hypernatremia. N Engl J Med. 2000;342(20):1493-1499.
    doi pubmed
  7. Lenz K, Gossinger H, Laggner A, Druml W, Grimm G, Schneeweiss B. Influence of hypernatremic-hyperosmolar state on hemodynamics of patients with normal and depressed myocardial function. Crit Care Med. 1986;14(10):913-914.
    doi pubmed
  8. DeVita MV, Gardenswartz MH, Konecky A, Zabetakis PM. Incidence and etiology of hyponatremia in an intensive care unit. Clin Nephrol. 1990;34(4):163-166.
  9. Palevsky PM, Bhagrath R, Greenberg A. Hypernatremia in hospitalized patients. Ann Intern Med. 1996;124(2):197-203.
    doi pubmed
  10. Stelfox HT, Ahmed SB, Khandwala F, Zygun D, Shahpori R, Laupland K. The epidemiology of intensive care unit-acquired hyponatraemia and hypernatraemia in medical-surgical intensive care units. Crit Care. 2008;12(6):R162.
    doi pubmed
  11. Vandergheynst F, Sakr Y, Felleiter P, Hering R, Groeneveld J, Vanhems P, Taccone FS, et al. Incidence and prognosis of dysnatraemia in critically ill patients: analysis of a large prevalence study. Eur J Clin Invest. 2013;43(9):933-948.
    doi pubmed
  12. Pokaharel M, Block CA. Dysnatremia in the ICU. Curr Opin Crit Care. 2011;17(6):581-593.
    doi pubmed
  13. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med. 1985;13(10):818-829.
    doi pubmed
  14. Bihari S, Peake SL, Bailey M, Pilcher D, Prakash S, Bersten A. Admission high serum sodium is not associated with increased intensive care unit mortality risk in respiratory patients. J Crit Care. 2014;29(6):948-954.
    doi pubmed
  15. Palepu R, Freebaim R. Electrolyte disorders in the critically ill. Anaesth Intens Care Med. 2014;15(2):78-82.
  16. DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics. 1988;44(3):837-845.
    doi pubmed
  17. Porcel A, Diaz F, Rendon P, Macias M, Martin-Herrera L, Giron-Gonzalez JA. Dilutional hyponatremia in patients with cirrhosis and ascites. Arch Intern Med. 2002;162(3):323-328.
    doi pubmed
  18. Bennani SL, Abouqal R, Zeggwagh AA, Madani N, Abidi K, Zekraoui A, Kerkeb O. [Incidence, causes and prognostic factors of hyponatremia in intensive care]. Rev Med Interne. 2003;24(4):224-229.
  19. Padhi R, Panda BN, Jagati S, Patra SC. Hyponatremia in critically ill patients. Indian J Crit Care Med. 2014;18(2):83-87.
    doi pubmed
  20. Tierney WM, Martin DK, Greenlee MC, Zerbe RL, McDonald CJ. The prognosis of hyponatremia at hospital admission. J Gen Intern Med. 1986;1(6):380-385.
    doi pubmed
  21. Sedlacek M, Schoolwerth AC, Remillard BD. Electrolyte disturbances in the intensive care unit. Semin Dial. 2006;19(6):496-501.
    doi pubmed
  22. Leung AA, McAlister FA, Rogers SO, Jr., Pazo V, Wright A, Bates DW. Preoperative hyponatremia and perioperative complications. Arch Intern Med. 2012;172(19):1474-1481.
    doi pubmed
  23. Liamis G, Kalogirou M, Saugos V, Elisaf M. Therapeutic approach in patients with dysnatraemias. Nephrol Dial Transplant. 2006;21(6):1564-1569.
    doi pubmed
  24. Hoorn EJ, Betjes MG, Weigel J, Zietse R. Hypernatraemia in critically ill patients: too little water and too much salt. Nephrol Dial Transplant. 2008;23(5):1562-1568.
    doi pubmed
  25. Lindner G, Kneidinger N, Holzinger U, Druml W, Schwarz C. Tonicity balance in patients with hypernatremia acquired in the intensive care unit. Am J Kidney Dis. 2009;54(4):674-679.
    doi pubmed
  26. Darmon M, Timsit JF, Francais A, Nguile-Makao M, Adrie C, Cohen Y, Garrouste-Orgeas M, et al. Association between hypernatraemia acquired in the ICU and mortality: a cohort study. Nephrol Dial Transplant. 2010;25(8):2510-2515.
    doi pubmed
  27. Lindner G, Funk GC, Lassnigg A, Mouhieddine M, Ahmad SA, Schwarz C, Hiesmayr M. Intensive care-acquired hypernatremia after major cardiothoracic surgery is associated with increased mortality. Intensive Care Med. 2010;36(10):1718-1723.
    doi pubmed
  28. Waite MD, Fuhrman SA, Badawi O, Zuckerman IH, Franey CS. Intensive care unit-acquired hypernatremia is an independent predictor of increased mortality and length of stay. J Crit Care. 2013;28(4):405-412.
    doi pubmed

This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Journal of Clinical Medicine Research is published by Elmer Press Inc.





Browse  Journals  


Journal of clinical Medicine Research

Journal of Endocrinology and Metabolism

Journal of Clinical Gynecology and Obstetrics

World Journal of Oncology

Gastroenterology Research

Journal of Hematology

Journal of Medical Cases

Journal of Current Surgery

Clinical Infection and Immunity

Cardiology Research

World Journal of Nephrology and Urology

Cellular and Molecular Medicine Research

Journal of Neurology Research

International Journal of Clinical Pediatrics






Journal of Clinical Medicine Research, monthly, ISSN 1918-3003 (print), 1918-3011 (online), published by Elmer Press Inc.            
The content of this site is intended for health care professionals.
This is an open-access journal distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License, which permits unrestricted
non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Creative Commons Attribution license (Attribution-NonCommercial 4.0 International CC-BY-NC 4.0)

This journal follows the International Committee of Medical Journal Editors (ICMJE) recommendations for manuscripts submitted to biomedical journals,
the Committee on Publication Ethics (COPE) guidelines, and the Principles of Transparency and Best Practice in Scholarly Publishing.

website: www.jocmr.org   editorial contact: editor@jocmr.org
Address: 9225 Leslie Street, Suite 201, Richmond Hill, Ontario, L4B 3H6, Canada

© Elmer Press Inc. All Rights Reserved.